# An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement

> **NCT01964157** · PHASE2 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 32 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** LDK378

## Key facts

- **NCT ID:** NCT01964157
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2019-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964157, "An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01964157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*